2009 AVAC Report: Piecing Together the HIV Prevention Puzzle

The 2009 AVAC Report, Piecing Together the HIV Prevention Puzzle, took inspiration from a quotation in the 2006-2008 review of the Bill & Melinda Gates Foundation-funded Collaboration for AIDS Vaccine Discovery, which states that the ultimate goal “is to develop a vaccine that prevents HIV infection or disease, anything less than that can be characterized as progress, but not success.”

The first section of the Report, “Puzzling Out Progress,” reports on the AIDS vaccine field, where there’s an energized focus on discovery, innovation, and basic science. The second section, “Puzzling Out Success,” turns to the implications of PrEP and other strategies in efficacy trials today. Throughout, it is argued that success will depend on combination approaches: on research plus implementation; on vaccines plus PrEP, should either show benefit; and on communities plus researchers working towards common goals.

Good Participatory Practice: Guidelines for biomedical HIV prevention trials second edition (French)

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials.

This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials and Good Participatory Practices in Biomedical HIV Prevention Trials. The sections provide context, foundational principles and key practices.

2008 AVAC Report: The Search Must Continue

The 2008 AVAC Report, The Search Must Continue, provides a comprehensive review of recent developments in AIDS vaccine research. It explores the issues that have been raised in the wake of the failure of Merck’s vaccine candidate and provides context for the events and major changes of the last year in HIV prevention research.

Good Participatory Practice: Guidelines for biomedical HIV prevention trials second edition (Khmer)

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials.

This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials and Good Participatory Practices in Biomedical HIV Prevention Trials. The sections provide context, foundational principles and key practices.

Good Participatory Practice: Guidelines for biomedical HIV prevention trials second edition (Arabic)

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials.

This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials and Good Participatory Practices in Biomedical HIV Prevention Trials. The sections provide context, foundational principles and key practices.

2007 AVAC Report: Resetting the Clock

The three sections of this year’s report outline some specific deadlines and challenges in AIDS vaccine scientific strategy, clinical trials, and the broader realm of HIV prevention. These arenas mesh like watch gears, and must function just as smoothly if the field is to proceed.

Good Participatory Practice: Guidelines for biomedical HIV prevention trials second edition (Vietnamese)

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials.

This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials and Good Participatory Practices in Biomedical HIV Prevention Trials. The sections provide context, foundational principles and key practices.

Good Participatory Practice: Guidelines for biomedical HIV prevention trials second edition (Chinese)

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials.

This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials and Good Participatory Practices in Biomedical HIV Prevention Trials. The sections provide context, foundational principles and key practices.

Good Participatory Practice: Guidelines for biomedical HIV prevention trials second edition (Spanish)

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials.

This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials and Good Participatory Practices in Biomedical HIV Prevention Trials. The sections provide context, foundational principles and key practices.

2006 AVAC Report: AIDS Vaccines: The Next Frontiers

In this report, AVAC offers its first contribution to the scenario planning critical to the success of the field. The next several years bring a variety of scenarios which cannot be encountered unprepared. Instead, the AIDS vaccine field, and the field of prevention research in general, must engage in rigorous debate, dialogue and scenario planning which anticipates the issues that the next few years will bring, and ensures that the wide range of stakeholders are informed and empowered to make decisions to compete against the virus. In this report, four thought-provoking chapters are presented, each of which begins with a future scenario that considers how the world might look in five or six or ten years’ time.